• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

质子泵抑制剂奥美拉唑与各种肠溶包衣聚合物之间的固态相互作用。

Solid state interactions between the proton pump inhibitor omeprazole and various enteric coating polymers.

作者信息

Stroyer A, McGinity J W, Leopold C S

机构信息

College of Pharmacy, University of Texas at Austin, TX, USA.

出版信息

J Pharm Sci. 2006 Jun;95(6):1342-53. doi: 10.1002/jps.20450.

DOI:10.1002/jps.20450
PMID:16625655
Abstract

The influence of the acidic film formers Eudragit L 100, HPMCAS-HF, HP-55, and shellac on the stability of the acid-labile proton pump inhibitor omeprazole in solid drug-polymer blends at accelerated storage conditions (40 degrees C/75% RH) was determined by fourier transform infrared spectroscopy (FTIR), modulated temperature differential scanning calorimetry (MTDSC), and high performance liquid chromatography (HPLC). As expected, acidic polymers caused a degradation of omeprazole which was manifested by discolorations and increasing amounts of degradation products. However, MTDSC curves and FTIR spectra did not show additional peaks resulting from the omeprazole degradation products. These methods appeared to be not sensitive enough to separate analytically the drug and polymer signals from those of the decomposition products. With HPLC a sufficient quantification of the degradation products was possible. HP-55 caused the highest degree of omeprazole degradation, followed by shellac, HPMCAS-HF, and Eudragit L 100. No correlation with the microenvironmental pH values generated by the acidic polymers at the applied storage conditions was found. The melting process and the dissolution of acidic impurities were figured out as possible reasons for the more pronounced decomposition of the drug in presence of HP-55 and shellac.

摘要

通过傅里叶变换红外光谱(FTIR)、调制温度差示扫描量热法(MTDSC)和高效液相色谱法(HPLC),测定了酸性成膜剂尤特奇L 100、羟丙甲纤维素醋酸琥珀酸酯-高取代度(HPMCAS-HF)、HP-55和虫胶在加速储存条件(40℃/75%相对湿度)下对固体药物-聚合物混合物中酸不稳定质子泵抑制剂奥美拉唑稳定性的影响。正如预期的那样,酸性聚合物导致奥美拉唑降解,表现为变色和降解产物量增加。然而,MTDSC曲线和FTIR光谱未显示出由奥美拉唑降解产物产生的额外峰。这些方法似乎不够灵敏,无法从分解产物的信号中解析分离出药物和聚合物信号。使用HPLC可以对降解产物进行充分定量。HP-55导致的奥美拉唑降解程度最高,其次是虫胶、HPMCAS-HF和尤特奇L 100。在所应用的储存条件下,未发现与酸性聚合物产生的微环境pH值相关。药物在HP-55和虫胶存在下分解更明显的可能原因被认为是熔融过程和酸性杂质的溶解。

相似文献

1
Solid state interactions between the proton pump inhibitor omeprazole and various enteric coating polymers.质子泵抑制剂奥美拉唑与各种肠溶包衣聚合物之间的固态相互作用。
J Pharm Sci. 2006 Jun;95(6):1342-53. doi: 10.1002/jps.20450.
2
Degradation of omeprazole induced by enteric polymer solutions and aqueous dispersions: HPLC investigations.肠溶聚合物溶液和水分散体诱导的奥美拉唑降解:高效液相色谱研究
Drug Dev Ind Pharm. 2005 Jan;31(2):151-60. doi: 10.1081/ddc-200047787.
3
Quantification of omeprazole degradation by enteric coating polymers: an UV-VIS spectroscopy study.肠溶包衣聚合物对奥美拉唑降解的定量研究:一项紫外可见光谱研究。
Pharmazie. 2005 Feb;60(2):126-30.
4
Solid-state interactions at the core-coat interface: physicochemical characterization of enteric-coated omeprazole pellets without a protective sub-coat.核-包衣界面的固态相互作用:无保护性底包衣的肠溶包衣奥美拉唑微丸的物理化学表征
AAPS PharmSciTech. 2015 Aug;16(4):934-43. doi: 10.1208/s12249-014-0263-z. Epub 2015 Jan 17.
5
Blends of reverse enteric polymer with Enteric and pH-independent polymers: mechanistic investigations for tailoring drug release.反向肠溶聚合物与肠溶和pH非依赖性聚合物的共混物:定制药物释放的机理研究。
Biomacromolecules. 2007 Jan;8(1):240-51. doi: 10.1021/bm060540+.
6
Investigations on the thermal behavior of omeprazole and other sulfoxides.奥美拉唑及其他亚砜类化合物的热行为研究。
Pharmazie. 2005 Jul;60(7):503-7.
7
Dissolution test for liquid formulations of omeprazole enteric-coated products.奥美拉唑肠溶制剂液体制剂的溶出度试验。
Ann Pharmacother. 2003 Jan;37(1):150-1. doi: 10.1345/aph.1A247.
8
Effect of Elevated pH on the Commercial Enteric-Coated Omeprazole Pellets Resistance: Patent Review and Multisource Generics Comparison.升高 pH 值对商业肠溶包衣奥美拉唑微丸抗酸能力的影响:专利审查和仿制药比较
AAPS PharmSciTech. 2021 Jun 22;22(5):188. doi: 10.1208/s12249-021-02038-2.
9
Instantaneous enteric nano-encapsulation of omeprazole: pharmaceutical and pharmacological evaluation.奥美拉唑的即时肠道纳米包封:药学和药理学评价
Int J Pharm. 2014 Jul 1;468(1-2):97-104. doi: 10.1016/j.ijpharm.2014.04.030. Epub 2014 Apr 16.
10
The manufacture and characterisation of hot-melt extruded enteric tablets.热熔挤出肠溶片剂的制造与表征
Eur J Pharm Biopharm. 2008 May;69(1):264-73. doi: 10.1016/j.ejpb.2007.11.001. Epub 2007 Nov 13.

引用本文的文献

1
Emerging Applications of Hydroxypropyl Methylcellulose Acetate Succinate: Different Aspects in Drug Delivery and Its Commercial Potential.羟丙甲纤维素琥珀酸酯的新兴应用:药物传递中的不同方面及其商业潜力。
AAPS PharmSciTech. 2023 Sep 15;24(7):188. doi: 10.1208/s12249-023-02645-1.
2
Molecular Interactions between APIs and Enteric Polymeric Excipients in Solid Dispersion: Insights from Molecular Simulations and Experiments.固体分散体中活性药物成分与肠溶聚合物辅料之间的分子相互作用:来自分子模拟和实验的见解
Pharmaceutics. 2023 Apr 6;15(4):1164. doi: 10.3390/pharmaceutics15041164.
3
Formulation of Dosage Forms with Proton Pump Inhibitors: State of the Art, Challenges and Future Perspectives.
质子泵抑制剂剂型的研发:现状、挑战与未来展望
Pharmaceutics. 2022 Sep 25;14(10):2043. doi: 10.3390/pharmaceutics14102043.
4
Hot-Melt Extrusion: a Roadmap for Product Development.热熔挤出:产品开发路线图。
AAPS PharmSciTech. 2021 Jun 17;22(5):184. doi: 10.1208/s12249-021-02017-7.
5
Effects of Cyclodextrins (β and γ) and l-Arginine on Stability and Functional Properties of Mucoadhesive Buccal Films Loaded with Omeprazole for Pediatric Patients.环糊精(β-环糊精和γ-环糊精)和L-精氨酸对载有奥美拉唑的儿科用黏附性口腔膜稳定性和功能特性的影响
Polymers (Basel). 2018 Feb 7;10(2):157. doi: 10.3390/polym10020157.
6
Melt extrusion with poorly soluble drugs - An integrated review.热熔挤出技术在难溶性药物中的应用-综合述评。
Int J Pharm. 2018 Jan 15;535(1-2):68-85. doi: 10.1016/j.ijpharm.2017.10.056. Epub 2017 Nov 2.
7
Solid-state interactions at the core-coat interface: physicochemical characterization of enteric-coated omeprazole pellets without a protective sub-coat.核-包衣界面的固态相互作用:无保护性底包衣的肠溶包衣奥美拉唑微丸的物理化学表征
AAPS PharmSciTech. 2015 Aug;16(4):934-43. doi: 10.1208/s12249-014-0263-z. Epub 2015 Jan 17.
8
Eudragit L/HPMCAS blend enteric-coated lansoprazole pellets: enhanced drug stability and oral bioavailability.聚丙烯酸树脂L/羟丙基甲基纤维素醋酸琥珀酸酯共混物包衣的兰索拉唑微丸:增强药物稳定性和口服生物利用度。
AAPS PharmSciTech. 2014 Jun;15(3):513-21. doi: 10.1208/s12249-013-0035-1. Epub 2014 Mar 5.
9
Enhanced dissolution and stability of lansoprazole by cyclodextrin inclusion complexation: preparation, characterization, and molecular modeling.环糊精包合增强兰索拉唑的溶解和稳定性:制备、表征和分子模拟。
AAPS PharmSciTech. 2012 Dec;13(4):1222-9. doi: 10.1208/s12249-012-9842-z. Epub 2012 Sep 12.
10
A comprehensive development strategy in buccal drug delivery.口腔药物传递的综合发展策略。
AAPS PharmSciTech. 2010 Dec;11(4):1703-12. doi: 10.1208/s12249-010-9546-1. Epub 2010 Nov 30.